Clinical trials for Lymphoma
95 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Lymphoma
#NCT05283720
#2023-505347-38-00
B cell lymphoma
Mantel cell lymphoma
None
1
2
3 or more
Bispecific T-cell engager antibodies
8 recruiting sites
Abbvie
Phase 2
Lymphoma
#NCT06534437
#2024-513098-31-00
B cell lymphoma
Large B cell lymphoma
Indolent transformed lymphoma
None
2
3 or more
Chemotherapy
Bispecific T-cell engager antibodies
Monoclonal antibodies
Systemic Treatment-Naive
7 recruiting sites
Ryvu Therapeutics SA
Phase 2
Lymphoma
#NCT05139017
#2022-502646-27-00
B cell lymphoma
Large B cell lymphoma
None
Treated / Controled
1
2
3 or more
Car-T
Autologous stem cell transplant
Systemic Treatment-Naive
1 recruiting site
Merck Sharp & Dohme LLC
Phase 2
Lymphoma
#NCT06526793
B cell lymphoma
Large B cell lymphoma
Follicular lymphoma
None
Treated / Controled
> 60 ml/min
50-60 ml/min
30-50 ml/min
2
3 or more
Systemic Treatment-Naive
5 recruiting sites
AstraZeneca
Phase 2
Lymphoma
#NCT04728893
#2023-504931-42-00
B cell lymphoma
Mantel cell lymphoma
Follicular lymphoma
Marginal zone lymphoma
None
Treated / Controled
1
2
3 or more
Chemotherapy
Targeted therapy
Monoclonal antibodies
Systemic Treatment-Naive
4 recruiting sites
Merck Sharp & Dohme LLC
Phase 2
Lymphoma
#NCT06482684
#2022-502405-15-01
B cell lymphoma
Mantel cell lymphoma
Early (stage I and II)
Disseminated (stage III and IV)
None
> 60 ml/min
None
Systemic Treatment-Naive
2 recruiting sites
Ludwig-Maximilians - Université de Munich
Phase 2
Lymphoma
#NCT03328078
#2024-513312-95-00
B cell lymphoma
Primary cerebral lymphoma
1
2
3 or more
Systemic Treatment-Naive
4 recruiting sites
Curis, Inc.
Phase 2
Lymphoma
#NCT06271057
#2023-506705-20-00
B cell lymphoma
Large B cell lymphoma
Primary mediastinal lymphoma
Indolent transformed lymphoma
> 60 ml/min
2
3 or more
Systemic Treatment-Naive
13 recruiting sites
The Lymphoma Academic Research Organisation (LYSARC)
Phase 2
Lymphoma
#NCT06588478
#2024-515689-15-01
B cell lymphoma
Lymphocytic lymphoma
None
None
Systemic Treatment-Naive
6 recruiting sites
Loxo Oncology
Phase 2
Lymphoma
#NCT06588478
#2024-515689-15-01
B cell lymphoma
Lymphocytic lymphoma
None
1
2
3 or more
Targeted therapy
Systemic Treatment-Naive
6 recruiting sites
Loxo Oncology